115 related articles for article (PubMed ID: 38347781)
21. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
Liu W; Yin C; Liu Y
Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
[No Abstract] [Full Text] [Related]
23. Silencing of FGF6 hampers aerobic glycolysis and angiogenesis in bladder cancer by regulating PI3K/Akt and MAPK signaling pathways.
Zhi Y; Cai C; Xu T; Sun F; Wang KP; Ji Z; Pei Y; Geng S; Wang H
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23399. PubMed ID: 37345681
[TBL] [Abstract][Full Text] [Related]
24. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
25. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
26. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q
J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558
[TBL] [Abstract][Full Text] [Related]
29. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
30. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J
Cancer Biol Ther; 2023 Dec; 24(1):2225884. PubMed ID: 37382415
[TBL] [Abstract][Full Text] [Related]
31. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
32. CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression
Chen Z; Hao W; Tang J; Gao WQ; Xu H
Front Oncol; 2022; 12():897804. PubMed ID: 35875122
[TBL] [Abstract][Full Text] [Related]
33. MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the
Liu M; Du Q; Mao G; Dai N; Zhang F
Bioengineered; 2022 Mar; 13(3):5344-5356. PubMed ID: 35176941
[TBL] [Abstract][Full Text] [Related]
34. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
36. NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma.
Li X; Li Y; Bai S; Zhang J; Liu Z; Yang J
Cancer Manag Res; 2021; 13():427-437. PubMed ID: 33488124
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.
Xu Y; Xia D; Huang K; Liang M
J Transl Med; 2024 Jan; 22(1):74. PubMed ID: 38238754
[TBL] [Abstract][Full Text] [Related]
38. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
[TBL] [Abstract][Full Text] [Related]
39. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
40. NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target.
Huang H; Hua Q
Int J Genomics; 2022; 2022():8348499. PubMed ID: 35535347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]